Branchio-oto-renal syndrome

Last updated
Branchio-oto-renal syndrome
Other namesBOR syndrome, Branchiootorenal syndrome
Autosomal dominant - en.svg
Branchio-oto-renal syndrome has an autosomal dominant pattern of inheritance.
Specialty Medical genetics   OOjs UI icon edit-ltr-progressive.svg
Symptoms Ear abnormalities [1]
CausesMutations in genes, EYA1, SIX1, and SIX5 [2]
Diagnostic method Laboratory test results, Physical exam [3]
TreatmentBranchial fistula may need surgery [3]

Branchio-oto-renal syndrome (BOR) [4] [5] is an autosomal dominant genetic disorder involving the kidneys, ears, and neck. It is also known as Melnick-Fraser syndrome. [2] [3]

Contents

Signs and symptoms

The signs and symptoms of branchio-oto-renal syndrome are consistent with underdeveloped (hypoplastic) or absent kidneys with resultant chronic kidney disease or kidney failure. Ear anomalies include extra openings in front of the ears, extra pieces of skin in front of the ears (preauricular tags), or further malformation or absence of the outer ear (pinna). Malformation or absence of the middle ear is also possible, individuals can have mild to profound hearing loss. People with BOR may also have cysts or fistulae along the sides of their neck. [1] In some individuals and families, renal features are completely absent. The disease may then be termed "branchio-oto syndrome" (BO syndrome). [6] [7]

Cause

The cause of branchio-oto-renal syndrome are mutations in genes, EYA1, SIX1, and SIX5 (approximately 40 percent of those born with this condition have a mutation in the EYA1 gene). [1] [8] Many different abnormalities in these genes have been identified. [9]

Mechanism

The genetics of branchio-oto-renal syndrome indicate it is inherited in an autosomal dominant manner with variable clinical manifestations affecting branchial, renal, and auditory development. Autosomal dominant inheritance indicates that the defective gene responsible for a disorder is located on an autosome, and only one copy of the gene is sufficient to cause the disorder, when inherited from a parent who has the disorder. The varying clinical expression of the disease between different families suggests that multiple loci may be involved. In 1992, using genetic linkage studies, the BOR gene was identified on chromosome 8, [10] Subsequently, another locus on human chromosome 14 was identified, and several mutations were reported in genes EYA1, SIX1, [11] and SIX5. [12] [13] SINX1 is involved in many facets of embryonic development and is important in the normal formation of many organs and tissues, including the ears, and kidneys before birth. [14]

Diagnosis

Diagnosis of BO syndrome or BOR syndrome is clinical, i.e. based on observing an appropriate combination of symptoms. [6] Only about half of patients have a detectable genetic abnormality, mostly in the EYA1 gene, SIX1 gene or the SIX5 gene. [6]

Treatment

Otitis media -acute Otitis media entdifferenziert2.jpg
Otitis media -acute

The treatment of branchio-oto-renal syndrome is done per each affected area (or organ). For example, a person with hearing problems should have appropriate supports and prompt attention for any inflammation of the ear. [6] [15]

A specialist should observe any kidney problems. Surgical repair may be needed depending on the degree of a defect or problem, whether a transplant or dialysis is needed. [16]

Epidemiology

The epidemiology of branchio-oto-renal syndrome has it with a prevalence of 1/40,000 in Western countries. A 2014 review found 250 such cases in the country of Japan. [17]

See also

Related Research Articles

<span class="mw-page-title-main">Alport syndrome</span> Medical condition

Alport syndrome is a genetic disorder affecting around 1 in 5,000-10,000 children, characterized by glomerulonephritis, end-stage kidney disease, and hearing loss. Alport syndrome can also affect the eyes, though the changes do not usually affect vision, except when changes to the lens occur in later life. Blood in urine is universal. Proteinuria is a feature as kidney disease progresses.

Renal agenesis is a medical condition in which one (unilateral) or both (bilateral) fetal kidneys fail to develop.

<span class="mw-page-title-main">Pendred syndrome</span> Medical condition

Pendred syndrome is a genetic disorder leading to congenital bilateral sensorineural hearing loss and goitre with euthyroid or mild hypothyroidism. There is no specific treatment, other than supportive measures for the hearing loss and thyroid hormone supplementation in case of hypothyroidism. It is named after Vaughan Pendred (1869–1946), the British doctor who first described the condition in an Irish family living in Durham in 1896. It accounts for 7.5% to 15% of all cases of congenital deafness.

<span class="mw-page-title-main">Barakat syndrome</span> Disease characterized by hypoparathyroidism, sensorineural deafness and renal disease

Barakat syndrome is a rare disease characterized by hypoparathyroidism, sensorineural deafness and renal disease, and hence also known as HDR syndrome. It is an autosomal dominant condition with incomplete penetrance and variable expressivity that was first described by Amin J. Barakat et al. in 1977.

The metanephrogenic blastema or metanephric blastema is one of the two embryological structures that give rise to the kidney, the other being the ureteric bud.

<span class="mw-page-title-main">Robinow syndrome</span> Rare genetic disorder characterized by a fetal face

Robinow syndrome is an extremely rare genetic disorder characterized by short-limbed dwarfism, abnormalities in the head, face, and external genitalia, as well as vertebral segmentation. The disorder was first described in 1969 by human geneticist Meinhard Robinow, along with physicians Frederic N. Silverman and Hugo D. Smith, in the American Journal of Diseases of Children. By 2002, over 100 cases had been documented and introduced into medical literature.

<span class="mw-page-title-main">Duane-radial ray syndrome</span> Medical condition

Duane-radial ray syndrome, also known as Okihiro syndrome, is a rare autosomal dominant disorder that primarily affects the eyes and causes abnormalities of bones in the arms and hands. This disorder is considered to be a SALL4-related disorder due to the SALL4 gene mutations leading to these abnormalities. It is diagnosed by clinical findings on a physical exam as well as genetic testing and imaging. After being diagnosed, there are other evaluations that one may go through in order to determine the extent of the disease. There are various treatments for the symptoms of this disorder.

Denys–Drash syndrome (DDS) or Drash syndrome is a rare disorder or syndrome characterized by gonadal dysgenesis, nephropathy, and Wilms' tumor.

<span class="mw-page-title-main">Papillorenal syndrome</span> Medical condition

Papillorenal syndrome is an autosomal dominant genetic disorder marked by underdevelopment (hypoplasia) of the kidney and colobomas of the optic nerve.

Pendrin is an anion exchange protein that in humans is encoded by the SLC26A4 gene . Pendrin was initially identified as a sodium-independent chloride-iodide exchanger with subsequent studies showing that it also accepts formate and bicarbonate as substrates. Pendrin is similar to the Band 3 transport protein found in red blood cells. Pendrin is the protein which is mutated in Pendred syndrome, which is an autosomal recessive disorder characterized by sensorineural hearing loss, goiter and a partial organification problem detectable by a positive perchlorate test.

<span class="mw-page-title-main">Townes–Brocks syndrome</span> Medical condition

Townes–Brocks syndrome (TBS) is a rare genetic disease that has been described in approximately 200 cases in the published literature. It affects both males and females equally. The condition was first identified in 1972. by Philip L. Townes, who was at the time a human geneticists and Professor of Pediatrics, and Eric Brocks, who was at the time a medical student, both at the University of Rochester.

<span class="mw-page-title-main">MYO7A</span> Protein-coding gene in the species Homo sapiens

Myosin VIIA is protein that in humans is encoded by the MYO7A gene. Myosin VIIA is a member of the unconventional myosin superfamily of proteins. Myosins are actin binding molecular motors that use the enzymatic conversion of ATP - ADP + inorganic phosphate (Pi) to provide the energy for movement.

<span class="mw-page-title-main">Multicystic dysplastic kidney</span> Medical condition

Multicystic dysplastic kidney (MCDK) is a condition that results from the malformation of the kidney during fetal development. The kidney consists of irregular cysts of varying sizes. Multicystic dysplastic kidney is a common type of renal cystic disease, and it is a cause of an abdominal mass in infants.

<span class="mw-page-title-main">Eyes absent homolog 1</span> Protein-coding gene in the species Homo sapiens

Eyes absent homolog 1 is a protein that in humans is encoded by the EYA1 gene.

<span class="mw-page-title-main">Homeobox protein SIX1</span> Protein-coding gene in humans

Homeobox protein SIX1 is a protein that in humans is encoded by the SIX1 gene.

<span class="mw-page-title-main">Polycystic kidney disease</span> Congenital disorder of urinary system

Polycystic kidney disease is a genetic disorder in which the renal tubules become structurally abnormal, resulting in the development and growth of multiple cysts within the kidney. These cysts may begin to develop in utero, in infancy, in childhood, or in adulthood. Cysts are non-functioning tubules filled with fluid pumped into them, which range in size from microscopic to enormous, crushing adjacent normal tubules and eventually rendering them non-functional as well.

Lachiewicz–Sibley syndrome is a rare autosomal dominant disorder characterized by preauricular pits and renal disease. Persons with this disease may have hypoplasic kidneys or proteinuria. This disease was first described in a Caucasian family of British and Irish descent that emigrated to Ohio in the 19th century before settling in Nebraska. Many of the members of this family still live in Nebraska, although the relatives are now scattered throughout the country.

<span class="mw-page-title-main">Branchio-oculo-facial syndrome</span> Medical condition

Branchio-oculo-facial syndrome (BOFS) is a disease that arises from a mutation in the TFAP2A gene. It is a rare autosomal dominant disorder that starts to affect a child's development before birth. Symptoms of this condition include skin abnormalities on the neck, deformities of the ears and eyes, and other distinctive facial features such a cleft lip along with slow growth, mental retardation and premature graying of hair.

<span class="mw-page-title-main">Otofaciocervical syndrome</span> Medical condition

Otofaciocervical syndrome, also known as Fara Chlupackova syndrome, are a small group of rare developmental disorders of genetic origin which are characterized by facial dysmorphisms, long neck, preauricular and/or branchial pits, cervical muscle hypoplasia, hearing loss, and mild intellectual disabilities. Additional findings include vertebral anomalies and short stature.

<span class="mw-page-title-main">Shrawan Kumar (geneticist)</span>

Shrawan Kumar, is an Indian-American geneticist, working in the fields of molecular and population genetics. He is known for his contributions in the discovery of two genes related to Branchio-oto-renal syndrome (BOR) and Autosomal Dominant Polycystic Kidney Disease (ADPKD2).

References

  1. 1 2 3 "Branchio Oto Renal Syndrome". NORD (National Organization for Rare Disorders). Archived from the original on 2020-09-26. Retrieved 2015-11-29.
  2. 1 2 "Branchiootorenal syndrome". Genetics Home Reference. U.S. National Library of Medicine. 2015-11-23. Archived from the original on 2016-02-29. Retrieved 2015-11-29.
  3. 1 2 3 "Branchiootorenal syndrome | Disease | Overview". Genetic and Rare Diseases Information Center (GARD) – an NCATS Program. Archived from the original on 2016-07-27. Retrieved 2015-11-29.
  4. Kumar S (2004). "Branchio-oto-renal Syndrome". In Willems PJ (ed.). Genetic Hearing Loss. New York: Marcel Dekker Inc. doi:10.1201/9780203913062. ISBN   9780203913062. Archived from the original on 2022-11-13. Retrieved 2022-11-13.
  5. Kumar S, Deffenbacher K, Cremers CW, Van Camp G, Kimberling WJ (1997). "Branchio-oto-renal syndrome: identification of novel mutations, molecular characterization, mutation distribution, and prospects for genetic testing". Genetic Testing. 1 (4): 243–251. doi:10.1089/gte.1997.1.243. PMID   10464653.
  6. 1 2 3 4 Smith RJ (1993-01-01). "Branchiootorenal Spectrum Disorder". In Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJ, et al. (eds.). Branchiootorenal Spectrum Disorders. Seattle (WA): University of Washington, Seattle. PMID   20301554. Archived from the original on 2021-03-09. Retrieved 2017-08-30.|updated, 2015|
  7. Kumar S, Marres HA, Cremers CW, Kimberling WJ (April 1998). "Autosomal-dominant branchio-otic (BO) syndrome is not allelic to the branchio-oto-renal (BOR) gene at 8q13". American Journal of Medical Genetics. 76 (5): 395–401. doi:10.1002/(sici)1096-8628(19980413)76:5<395::aid-ajmg6>3.0.co;2-m. PMID   9556298.
  8. Little MH (2015-08-06). Kidney Development, Disease, Repair and Regeneration. Academic Press. p. 269. ISBN   9780128004388.
  9. Smith RJ (1993). Adam MP, Everman DB, Mirzaa GM, Pagon RA (eds.). Branchiootorenal Spectrum Disorder. Seattle (WA): University of Washington, Seattle. PMID 20301554
  10. Kumar S, Kimberling WJ, Kenyon JB, Smith RJ, Marres HA, Cremers CW (October 1992). "Autosomal dominant branchio-oto-renal syndrome--localization of a disease gene to chromosome 8q by linkage in a Dutch family". Human Molecular Genetics. 1 (7): 491–495. doi:10.1093/hmg/1.7.491. PMID   1307249.
  11. Ruf RG, Xu PX, Silvius D, Otto EA, Beekmann F, Muerb UT, et al. (May 2004). "SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes". Proceedings of the National Academy of Sciences of the United States of America. 101 (21): 8090–8095. Bibcode:2004PNAS..101.8090R. doi: 10.1073/pnas.0308475101 . PMC   419562 . PMID   15141091.
  12. Krug P, Morinière V, Marlin S, Koubi V, Gabriel HD, Colin E, et al. (February 2011). "Mutation screening of the EYA1, SIX1, and SIX5 genes in a large cohort of patients harboring branchio-oto-renal syndrome calls into question the pathogenic role of SIX5 mutations" (PDF). Human Mutation. 32 (2): 183–190. doi:10.1002/humu.21402. PMID   21280147. S2CID   25826641. Archived (PDF) from the original on 2022-11-13. Retrieved 2022-11-13.
  13. Online Mendelian Inheritance in Man (OMIM): Branchiootorenal Syndrome 1; BOR1 - 113650
  14. Mehdizadeh T, Majumdar HD, Ahsan S, Tavares AL, Moody SA (June 2021). "Mutations in SIX1 Associated with Branchio-oto-Renal Syndrome (BOR) Differentially Affect Otic Expression of Putative Target Genes". Journal of Developmental Biology. 9 (3): 25. doi: 10.3390/jdb9030025 . PMC   8293042 . PMID   34208995.
  15. Niparko JK (2009-01-01). Cochlear Implants: Principles & Practices. Lippincott Williams & Wilkins. p. 53. ISBN   9780781777490. Archived from the original on 2023-01-12. Retrieved 2020-11-25.
  16. Izzedine H, Tankere F, Launay-Vacher V, Deray G (February 2004). "Ear and kidney syndromes: molecular versus clinical approach". Kidney International. 65 (2): 369–385. doi: 10.1111/j.1523-1755.2004.00390.x . PMID   14717907.
  17. Morisada N, Nozu K, Iijima K (June 2014). "Branchio-oto-renal syndrome: comprehensive review based on nationwide surveillance in Japan". Pediatrics International. 56 (3): 309–314. doi:10.1111/ped.12357. PMID   24730701. S2CID   40930806.

Further reading